Evolent Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2019 Annual Meeting of Stockholders held on June 11, 2019. The filing was submitted on June 12, 2019. Evolent Health, Inc. is a Delaware corporation with its principal executive offices in Arlington, Virginia.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Stockholders voted on three proposals. As of the record date (April 16, 2019), there were 81,908,947 shares of Class A common stock and 713,517 shares of Class B common stock outstanding and entitled to vote.
- Proposal 1 (Election of Directors): Stockholders elected two Class I director nominees for a three-year term expiring in 2022.
- Seth Blackley: 46,020,868 For; 19,152,757 Against; 18,561 Abstentions; 5,137,796 Non-Votes.
- David Farner: 42,149,534 For; 23,024,051 Against; 18,601 Abstentions; 5,137,796 Non-Votes.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- Results: 70,297,028 For; 18,692 Against; 14,262 Abstentions.
- Proposal 3 (Executive Compensation): Stockholders approved the compensation of named executive officers for 2018 on an advisory basis.
- Results: 60,381,772 For; 4,792,503 Against; 17,911 Abstentions; 5,137,796 Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the specific terms of the three-year director terms for Seth Blackley and David Farner.
- Confirm the engagement scope and fees for Deloitte & Touche LLP for the 2019 fiscal year.
- Review the definitive proxy statement (Schedule 14A) filed on April 30, 2019, for detailed descriptions of the proposals and executive compensation details.
- Note the significant number of non-votes (5,137,796) recorded for the director elections and executive compensation proposal.